WallStreetZenWallStreetZen

NASDAQ: MRX
Marex Group PLC Stock

$19.40+0.21 (+1.09%)
Updated Jun 18, 2024
MRX Price
$19.40
Fair Value Price
N/A
Market Cap
$1.38B
52 Week Low
$18.13
52 Week High
$23.45
P/E
16.58x
P/B
1,773,201.13x
P/S
N/A
PEG
0.37x
Dividend Yield
N/A
Revenue
$1.25k
Earnings
$128.00
Gross Margin
100%
Operating Margin
14.7%
Profit Margin
10.3%
Debt to Equity
21.88
Operating Cash Flow
$791
Beta
1.05
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

Zen Score

Industry Average (30)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how MRX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

MRX ($19.40) is trading below its intrinsic value of $24.86, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
MRX is good value based on its earnings relative to its share price (16.58x), compared to the US market average (31.44x)
P/E vs Market Valuation
MRX is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more MRX due diligence checks available for Premium users.

Be the first to know about important MRX news, forecast changes, insider trades & much more!

MRX News

Valuation

MRX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
16.58x
Industry
10.27x
Market
31.44x
MRX is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
MRX is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

MRX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1,773,201.13x
Industry
1.91x
MRX is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

MRX price to earnings growth (PEG)

For valuing profitable companies with growth potential
MRX is good value based... subscribe to Premium to read more.
PEG Value Valuation

MRX's financial health

Profit margin

Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
MRX's Earnings (EBIT) of $183.00... subscribe to Premium to read more.
Interest Coverage Financials
MRX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$17.8k
Liabilities
$17.0k
Debt to equity
21.88
MRX's short-term assets ($17.07k) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MRX's short-term assets ($17.07k) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MRX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
N/A
Investing
N/A
Financing
N/A
MRX's operating cash flow ($791.00)... subscribe to Premium to read more.
Debt Coverage Financials

MRX vs Capital Market Stocks

TickerMarket Cap1d %P/EP/B
MRX$1.38B+1.09%16.58x1,773,201.13x
PWP$1.37B+1.82%-14.39x8.45x
WULF$1.50B+2.73%-19.61x5.52x
CIFR$1.55B+0.20%83.50x2.58x
BITF$1.12B+0.32%N/A3.07x

Marex Group Stock FAQ

What is Marex Group's quote symbol?

(NASDAQ: MRX) Marex Group trades on the NASDAQ under the ticker symbol MRX. Marex Group stock quotes can also be displayed as NASDAQ: MRX.

If you're new to stock investing, here's how to buy Marex Group stock.

What is the 52 week high and low for Marex Group (NASDAQ: MRX)?

(NASDAQ: MRX) Marex Group's 52-week high was $23.45, and its 52-week low was $18.13. It is currently -17.27% from its 52-week high and 7% from its 52-week low.

How much is Marex Group's stock price per share?

(NASDAQ: MRX) Marex Group stock price per share is $19.40 today (as of Jun 18, 2024).

What is Marex Group's Market Cap?

(NASDAQ: MRX) Marex Group's market cap is $1.38B, as of Jun 20, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Marex Group's market cap is calculated by multiplying MRX's current stock price of $19.40 by MRX's total outstanding shares of 70,928,045.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.